Category: News
-

Canadian Cancer Clinical Trials Network to further improve equitable access to cancer clinical trials with new funding
Support from the Canadian Partnership Against Cancer will further advance 3CTN’s equity, diversity and inclusion initiatives and fund six new projects across Canada March 5th, 2025, TORONTO – The Canadian Partnership Against Cancer (CPAC) has awarded the Canadian Cancer Clinical Trials Network (3CTN) with $600,000 in additional funding to support further efforts to improve access
-

Patient Partner Learning & Education Grants
3CTN is excited to offer grant opportunities for Patient Partners across our Network to help cover the cost of participating in educational courses, meetings or conferences. These grants are intended to promote learning and development to enhance the impact of patient engagement in clinical trials across Canada. Individual requests of up to $1,500 will be
-

Revised EDI Framework and Toolkit in Collaboration with Queering Cancer
The latest edition of our Equity, Diversity, and Inclusion (EDI) Framework and Toolkit is now available. In collaboration with Kim Meeking, Co-Lead for Queering Cancer, we have enriched the toolkit with additional resources and best practices aimed at addressing the unique needs of sexual and gender diverse (SGD) communities. This updated revision includes new resources
-

EDI Toolkit and Resources
We recently add a new page to our website! The Equity, Diversity and Inclusion (EDI) in Clinical Trials contains EDI resources developed by 3CTN and our recently completed EDI Toolkit.
-

A Tool for Patient Partner Development
Embedding Patient and Public Involvement (PPI) as a means for helping assure patient values and perspectives are reflected in clinical trials conduct has been a founding priority of the Canadian Cancer Clinical Trials Network (3CTN). Our community of Patient Representatives guide and support trial activities locally at cancer centres and centrally through participation in Network
-

3CTN’s Executive Director talks CRAFT DCT model development
Stephen Sundquist joins the Decentralized: The Decentralized Trials and Research Podcast to talk about the CRAFT DCT model development and implementation strategy and Bianka Courcelle from CHU Sainte-Justine, shares the PI site perspective in implementing these trials.
-

Canada needs a national system for cancer clinical trials
Toronto Star – Clinical trials are the most effective means of ensuring we have better cancer treatments. Such an investment would help overcome many hurdles facing clinical trials – from underfunding and suboptimal testing capacity to inefficient and costly regulatory processes. By Janet Dancey Contributor “A bad system will beat a good person every time.” William Edwards Deming
-

2022-23 3CTN Impact Report
Check out the accomplishments of Network Sites and the 3CTN Coordinating Centre.
-

Network Pulse June 2023
Read about activities happening at 3CTN member sites and get important updates about 3CTN goals and achievements.
-

Network Pulse February 2023
Read about activities happening at 3CTN member sites and get important updates about 3CTN goals and achievements.
